May 2025 in “Orphanet Journal of Rare Diseases” TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.
Chemotherapy and radiotherapy do not significantly affect obstructive sleep apnea development.
Wnt-activating drugs generally do not increase cancer risk.
April 2025 in “Journal of Pioneering Medical Science” Topical minoxidil is safer and improves hair density better than oral minoxidil.
April 2025 in “Annals of Medicine” Compound glycyrrhizin with conventional treatments is effective and safe for hair regrowth in alopecia areata.
Testosterone's health effects are complex and not definitively understood.
April 2025 in “International Journal of Ayurvedic Medicine” Semecarpus anacardium Linn. may have health benefits, but more research is needed to confirm its safety and effectiveness.
April 2025 in “European Psychiatry” Mood stabilizers for bipolar disorder can cause skin issues, but severe reactions are rare.
March 2025 in “INDONESIAN JOURNAL OF PHARMACY” Macroalgae may help treat hair loss and could be used in new hair growth products.
March 2025 in “Archives of Dermatological Research” Combined microneedling with minoxidil improves hair growth more than minoxidil alone but may cause mild side effects.
March 2025 in “Archives of Plastic Surgery” PRP with microneedling works better than injection for hair loss treatment.
March 2025 in “Laboratory Investigation” MESTSV is a rare tumor that is mostly benign but needs long-term monitoring due to potential recurrence.
February 2025 in “International Journal of Molecular Sciences” Alkaloids help fight influenza in animals but need more research for human use.
February 2025 in “Healthcare” Caffeine may help with hair loss, but more research is needed.
January 2025 in “Journal of Dermatological Treatment” Combining low-level laser therapy with minoxidil doesn't improve hair loss treatment compared to using minoxidil alone.
January 2025 in “HORMONES” Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.
January 2025 in “Journal of Ayurveda and Integrated Medical Sciences” A holistic lifestyle and ethical practices are key to managing hair disorders and improving well-being.
January 2025 in “Skin Pharmacology and Physiology” Oxidative stress contributes to alopecia areata, suggesting antioxidant treatments might help.
Androgenetic alopecia in young males leads to lower self-esteem, increased anxiety, and higher depression risk.
January 2025 in “Open Science Framework” AA-PRP temporarily increases hair density in androgenetic alopecia but loses effectiveness over time.
January 2025 in “Figshare” Compound glycyrrhizin combined with conventional treatments effectively and safely promotes hair regrowth in alopecia areata patients.
January 2025 in “Open Science Framework” Hair disorders significantly affect self-image, mental health, and quality of life.
January 2025 in “International Journal of Medicine in Developing Countries” Combining fractional photothermolysis with minoxidil is more effective for hair growth than minoxidil alone.
January 2025 in “Figshare” Compound glycyrrhizin with conventional treatments is effective and safe for promoting hair regrowth in alopecia areata.
January 2025 in “Faculty of 1000 Research Ltd” Plant-based treatments may help reduce BPH symptoms, but more research is needed.
January 2025 in “The Pharma Innovation” Millets support sustainable development by improving nutrition, aiding climate resilience, and boosting economic viability, especially for Indian farmers.
December 2024 in “Pharmaceutics” Spironolactone nano-formulations show promise for treating skin disorders, but more research is needed for safety and effectiveness.
December 2024 in “Journal of Clinical Medicine” Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.
December 2024 in “Frontiers in Surgery” Waxing and epilation might help wound healing, but more research is needed.
December 2024 in “Journal of the European Academy of Dermatology and Venereology” Bimatoprost shows promise for treating vitiligo, especially when combined with other therapies.